Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Kano Therapeutics Inc.

Kano Therapeutics Inc.

Stage unknownCambridge, MABiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. May 6, 2024
    Form D equity offering · $5.0M (form d sold) · 4 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Kano Therapeutics Inc. filed Form D: $5,050,000 sold of $5,050,000, Biotechnology”
Investors on record
3 edges
People
1 officers, 2 directors
Timeline
1
  1. May 20, 2024
    Kano Therapeutics Inc. filed Form D: $5,050,000 sold of $5,050,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
19 observations
Every observation on this company